Inherited neuropathy can cause postpartum foot dropPETERS, Gary; HINDS, Nigel P.Anesthesia and analgesia. 2005, Vol 100, Num 2, pp 547-548, issn 0003-2999, 2 p.Article

Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y₁₂ receptor antagonist, compared with clopidogrel in patients with acute coronary syndromesSTOREY, Robert F; HUSTED, Steen; CANNON, Christopher P et al.Journal of the American College of Cardiology. 2007, Vol 50, Num 19, pp 1852-1856, issn 0735-1097, 5 p.Article

Evaluation of Drug-Induced Serious Hepatotoxicity (eDISH): Application of this Data Organization Approach to Phase III Clinical Trials of Rivaroxaban after Total Hip or Knee Replacement SurgeryWATKINS, Paul B; DESAI, Mehul; BERKOWITZ, Scott D et al.Drug safety. 2011, Vol 34, Num 3, pp 243-252, issn 0114-5916, 10 p.Article

Safely, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome : Primary results of the DISPERSE-2 trialCANNON, Christopher P; HUSTED, Steen; HARRINGTON, Robert A et al.Journal of the American College of Cardiology. 2007, Vol 50, Num 19, pp 1844-1851, issn 0735-1097, 8 p.Article

No influence of obesity on the pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatranSARICH, Troy C; TENG, Renli; PETERS, Gary R et al.Clinical pharmacokinetics. 2003, Vol 42, Num 5, pp 485-492, issn 0312-5963, 8 p.Article

Comparison ofximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacementFRANCIS, Charles W; BERKOWITZ, Scott D; COMP, Philip C et al.The New England journal of medicine. 2003, Vol 349, Num 18, pp 1703-1712, issn 0028-4793, 10 p.Article